LICI Q4 Results 2026 Preview: Date, Time, Expectations & Key Things To Watch

CompoundingAI Research Updated May 16, 2026 4 min read

Life Insurance Corporation of India (LICI) enters its Q4 FY26 earnings print following a period of sustained margin expansion and a strategic pivot toward non-par products. Investors will be looking for clarity on the sustainability of this VNB margin trajectory, the impact of recent persistency trends, and updates on the company's digital transformation initiatives.

Quick Details
Results dateMay 21, 2026
QuarterQ4 FY 2025-2026
Previous quarter revenueRs. 3,71,293 Crore
Previous quarter PATRs. 33,998 Crore
Previous quarter EBITDA marginNot applicable
Market capRs. 505,462.19 Cr
CMPRs. 799.15

LICI Q4 Results Date and Time

The board meeting is scheduled for May 21, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to recommend final dividend for FY2026.

An earnings call is scheduled for May 21, 2026, at 7:00 p.m. (IST) to discuss the Q4 and FY2026 results, represented by CEO & MD Shri R. Doraiswamy, MDs, CFO Shri Sunil Agrawal, and other senior executives.

What to expect from LICI's Q4 FY26 results

In its most recently reported quarter, LICI posted total premium income of Rs. 3,71,293 Crore, PAT of Rs. 33,998 Crore, and an EBITDA margin of Not applicable. The company has seen its Net VNB margin improve to 18.8% in 9M FY26, up 170 basis points YoY, as management continues to shift its product mix toward non-par offerings which reached 36.46% of Individual APE in the same period. While the company faces ongoing challenges with persistency in specific cohorts and a slight decline in market share to 57.07%, it has maintained a robust solvency ratio of 2.19 as of 9M FY26. The upcoming call will likely focus on the company's ability to maintain its margin trajectory despite regulatory shifts and the progress of its digital transformation initiatives like DIVE and Jeevan Samarth.

Key Things To Watch

Performance vs Guidance Tracking: Tracking management's stated goals for the fiscal year.

  • VNB margin improvement trajectory — on track with 18.8% in 9M FY26
  • Non-Par share increase — on track at 36.46% of Individual APE in 9M FY26
  • Expense ratio reduction — on track at 11.65% in 9M FY26 vs 12.42% in FY25

Strategic Updates: Key initiatives driving long-term operational efficiency.

  • Digital transformation progress including DIVE and Jeevan Samarth implementation timelines
  • Bancassurance revival plan following the decline in channel productivity
  • Health insurance investment status and potential stake acquisition plans

Operational Focus Areas: Metrics critical to maintaining market leadership.

  • Persistency improvement measures following declines in 13th and 49th month cohorts
  • Agent productivity roadmap to increase from the current average of ~12 policies per agent
  • Performance of the 8 new products launched during 9M FY26

Risks and Headwinds to Monitor: Regulatory and operational factors impacting the business.

  • RBC regime implementation timeline and its dynamic impact on solvency requirements
  • Status of tax disputes including the Rs. 7,099.97 Crore income tax demand for FY2021-22
  • Competitive pressure on market share and agency attrition monitoring

Frequently Asked Questions

When will LICI announce Q4 FY 2025-2026 results?

LICI will announce its Q4 FY 2025-2026 results on May 21, 2026.

Will LICI announce a dividend with these results?

Yes, the board meeting scheduled for May 21, 2026, includes an agenda to recommend a final dividend for FY2026.

What was LICI's total premium income in its previous quarter?

LICI reported a total premium income of Rs. 3,71,293 Crore in Q3 FY 2025-2026.

When does LICI expect its VNB margins to stabilize?

Management has expressed intent for an upward trajectory in VNB margins from Q1 to Q4, though they noted that outcomes depend on execution and regulatory variables.

Is LICI planning to enter the health insurance market?

LICI is currently evaluating opportunities to enhance its stake in a health insurance company. However, management has stated there is no immediate deadline for this acquisition.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now